AC Immune gets milestone payment to initiate Phase 2 trial of PI-2620
Category: #health  | By Mateen Dalal  | Date: 2019-09-19 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

AC Immune gets milestone payment to initiate Phase 2 trial of PI-2620

As cases of neurodegenerative diseases like Alzheimer’s and Parkinson’s are on a rise, biopharmaceutical firms are actively engaging in developing new clinical drugs. Companies are also gaining increased funding from partners to further their cause in this field.

AC Immune SA, a clinical-stage biopharmaceutical company that develops a novel treatment for neurodegenerative diseases, recently gained a milestone payment from partner Life Molecular Imaging to commence the Phase 2 trial of Tau PET (positron-emission tomography) tracer PI-2620.

According to reports, PI-2620 is developed using the firm’s patented Morphomer™ discovery platform in a joint venture with Life Molecular Imaging GmbH, a diagnostic imaging and molecular solutions provider.

The drug plays an important role in quantifying and detecting early Tau deposition in the brain. It also displays potential for non-AD Tauopathies like PSP (progressive supranuclear palsy).

Speaking on the move, Prof. Andrea Pfeifer, CEO, AC Immune, said that the clinical development of PI-2620 is built on its superior imaging and properties characteristics, further bolstering the ability of the company’s Morphomer™ technology and its capability to form lucrative partnerships with established companies like Life Molecular Imaging.

Reportedly, in 2014, Life Molecular Imaging and AC Immune entered into a global license deal for commercialization, development and research of AC Immune's Tau PET tracers supporting the diagnosis of potential Tau-related disorders.

In addition to the recent move, the biopharmaceutical firm was earlier awarded a new grant for its groundbreaking alpha-synuclein (a-syn) PET (positron-emission tomography) tracer program by The Michael J. Fox Foundation for Parkinson’s Research (MJFF).

Moreover, over the past four years, the company has received constant grant support from the foundation to advance the study of a-syn PET tracers which, if successful, could offer the world’s first imaging agent competent enough to precisely monitor and detect the progression of PD (Parkinson’s disease).

Source Credit: https://ir.acimmune.com/news-releases/news-release-details/ac-immune-receives-milestone-payment-connection-initiation-phase?field_nir_news_date_value%5bmin%5d=2019

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

Oral-B & iADH partner to make oral care positive & accessible for all

Oral-B & iADH partner to make oral care positive & accessible for all

By Mateen Dalal

Oral-B, a well-known American oral hygiene products brand, has reportedly inked a partnership deal with iADH (International Association of Disability and Oral Health), in order to make oral care more positive, accessible, and inclusive for disabled p...

NEA AND SLA SIGN MOU TO SHARE GLOBAL NAVIGATION SATELLITE SYSTEM (GNSS)-DERIVED MOISTURE DATA FOR WEATHER MONITORING APPLICATION

NEA AND SLA SIGN MOU TO SHARE GLOBAL NAVIGATION SATELLITE SYSTEM (GNSS)-DERIVED MOISTURE DATA FOR WEATHER MONITORING APPLICATION

By Mateen Dalal

Singapore, 2 August 2022 – The National Environment Agency (NEA) and the Singapore Land Authority (SLA) have signed a Memorandum of Understanding (MOU) to develop the use of Global Navigation Satellite System (GNSS) data obtained from SLA&rsqu...

Baidu launches Apollo RT6; seeks expansion of its robotaxi fleet

Baidu launches Apollo RT6; seeks expansion of its robotaxi fleet

By Mateen Dalal

Baidu, a leading China-based artificial intelligence (AI) company and search engine, has reportedly uncovered its most recent electric autonomous driving vehicle. As per credible sources, the new vehicle, Apollo RT6, will be a part of the robotaxi...